FDA Inspection
Recipharm MontsRecipharm Monts – FDA Inspection, Jun 9, 2015
Record Details
This FDA Inspection record concerns Recipharm Monts, with an inspection on June 9, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Recipharm Monts
- Inspection Date
- June 9, 2015
- Product Type
- Drugs
View Company Profile
ID · b0930f8a-db4b-4f30-83a8-668fdf63cee8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 940945
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Recipharm Monts
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Monts
- FDA Inspection 1181620 - 2022-10-18
- FDA Inspection 1116762 - 2019-03-29
- FDA Inspection 821445 - 2013-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.